DIAGNOSTIC VALIDITY OF CSF ALPHA-SYNUCLEIN TO PREDICT PSYCHOSIS IN PRODROMAL ALZHEIMER'S DISEASE
Por:
Monge-Agriles, J, Saez-Valero, J, Sanchez-Paya, J, Gasparini-Berenguer, R, Cortes-Gomez, M and Garcia-Ayllon, M
Publicada:
1 jul 2022
Resumen:
Filiaciones:
Monge-Agriles, J:
Hosp Gen Univ Alicante, Serv Neurol, Alicante, Spain
Saez-Valero, J:
Inst Invest Sanitaria & Biomed Alicante ISABIAL, Alicante, Spain
Hosp Gen Univ Elche, FISABIO, Unidad Invest, Valencia, Spain
Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, Alicante, Spain
Sanchez-Paya, J:
Inst Invest Sanitaria & Biomed Alicante ISABIAL, Alicante, Spain
Hosp Gen Univ Alicante, Serv Med Preventiva, Alicante, Spain
Gasparini-Berenguer, R:
Hosp Gen Univ Alicante, Serv Neurol, Alicante, Spain
Inst Invest Sanitaria & Biomed Alicante ISABIAL, Alicante, Spain
Cortes-Gomez, M:
Hosp Gen Univ Alicante, Serv Neurol, Alicante, Spain
Inst Invest Sanitaria & Biomed Alicante ISABIAL, Alicante, Spain
:
Hosp Gen Univ Elche, FISABIO, Unidad Invest, Valencia, Spain
Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, Alicante, Spain
Ctr Invest Biomed Red Enfermedades Neurodegenerat, San Joan Dalacant, Spain
|